Enliven Therapeutics (ELVN) Q4 2022 Earnings

10FebExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-2.24
-1.09
0.06
1.21

Details

Expected EPS
-0.786
Actual EPS
1.21
Surprise EPS
2
Surprise Percent
+253.94%

Description

Enliven Therapeutics (ELVN) has reported earnings of 1.21 per share for Q4 2022.

0 Comments

Share your thoughts